Total Payments
$5,233
2024 Payments
$1,142
Companies
37
Transactions
290
Medicare Patients
2,688
Medicare Billing
$96,669
Payment Breakdown by Category
Food & Beverage$4,891 (93.5%)
Education$341.97 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,891 | 268 | 93.5% |
| Education | $341.97 | 22 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $646.61 | 43 | $0 (2024) |
| Astellas Pharma US Inc | $436.70 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $357.51 | 18 | $0 (2023) |
| ABBVIE INC. | $357.36 | 23 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $328.62 | 21 | $0 (2020) |
| MAYNE PHARMA COMMERCIAL LLC | $272.64 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $221.75 | 14 | $0 (2022) |
| Hologic, LLC | $208.02 | 12 | $0 (2022) |
| Exeltis, USA Inc. | $205.50 | 11 | $0 (2024) |
| Amgen Inc. | $205.03 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,142 | 57 | Astellas Pharma US Inc ($199.46) |
| 2023 | $1,030 | 44 | MAYNE PHARMA COMMERCIAL LLC ($227.82) |
| 2022 | $712.30 | 38 | MAYNE PHARMA INC. ($157.72) |
| 2021 | $184.58 | 10 | AbbVie Inc. ($35.52) |
| 2020 | $140.40 | 9 | PFIZER INC. ($31.44) |
| 2019 | $757.30 | 52 | PFIZER INC. ($146.20) |
| 2018 | $662.21 | 41 | AMAG Pharmaceuticals, Inc. ($192.05) |
| 2017 | $603.51 | 39 | PFIZER INC. ($151.66) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: WOMENS HEALTH | ||||||
| 12/09/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Neurology | ||||||
| 12/02/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/19/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: ETONOGESTREL | ||||||
| 11/12/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Biological | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/09/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.63 | General |
| 10/07/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Neurology | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Biological | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Bone Health | ||||||
| 09/16/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: Biological | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Biological | ||||||
| 07/16/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Neurology | ||||||
| 06/25/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $17.72 | General |
| 06/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Biological | ||||||
| 06/14/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $23.02 | General |
| 06/11/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: OB/GYN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 606 | 628 | $70,145 | $25,605 |
| 2022 | 8 | 622 | 648 | $61,276 | $21,503 |
| 2021 | 8 | 747 | 784 | $46,644 | $27,201 |
| 2020 | 6 | 713 | 734 | $39,785 | $22,360 |
Total Patients
2,688
Total Services
2,794
Medicare Billing
$96,669
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82274 | Stool analysis for blood | Office | 2020 | 166 | 167 | $5,845 | $2,646 | 45.3% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 196 | 199 | $4,378 | $791.80 | 18.1% |
About Dr. Mary Poag, MD
Dr. Mary Poag, MD is a Gynecology healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275595969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Poag, MD has received a total of $5,233 in payments from pharmaceutical and medical device companies, with $1,142 received in 2024. These payments were reported across 290 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,891).
As a Medicare-enrolled provider, Poag has provided services to 2,688 Medicare beneficiaries, totaling 2,794 services with total Medicare billing of $96,669. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Webster, TX
- Active Since 04/06/2006
- Last Updated 10/28/2024
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1275595969
Products in Payments
- PREMARIN (Drug) $402.43
- Veozah (Drug) $306.62
- INTRAROSA (Drug) $253.64
- Kyleena (Drug) $203.77
- MYFEMBREE (Drug) $193.53
- EVENITY (Biological) $174.57
- Mirena (Drug) $153.74
- Orilissa (Drug) $151.67
- NUVARING (Drug) $142.52
- NEXPLANON (Drug) $142.48
- LO LOESTRIN FE (Drug) $138.49
- PREMARIN ORALS (Drug) $122.11
- ZURZUVAE (Drug) $121.84
- MYRISK (Device) $115.60
- FEMRING (Drug) $105.62
- Tymlos (Biological) $95.34
- Myrbetriq (Drug) $94.79
- SLYND (Drug) $88.43
- MAKENA (Drug) $83.40
- ABRYSVO (Biological) $80.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.